High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$197K
$197,537
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
APLS
S
Apellis Pharmaceuticals, Inc.
Deschatelets Pascal
• Officer • Chief Scientific Officer
Sell to Cover
2026-01-22
$129,025
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-01-22 | $129,025 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Deschatelets Pascal
• Officer • Chief Scientific Officer
Sell to Cover
2026-01-20
$17,992
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-01-20 | $17,992 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Deschatelets Pascal
• Officer • Chief Scientific Officer
Sell to Cover
2026-01-13
$50,520
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-01-13 | $50,520 | S | Form 4 |